ARCHIVES

Efaproxyn Improved Survival Of Patients With Brain Mets

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Ruffin Sworn In As Director, NIH Minority Health Center.

January 12, 2001

Richard Pazdur’s Comments to ODAC

July 22, 2011

Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change.

September 30, 2005

Hughes institute Considers More Support For Genome Mapping

August 1, 1986

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013